Cite
MLA Citation
H. Tsuda et al.. “The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer.” International journal of gynecological cancer, vol. 12, no. 5, 2002, pp. 435–437. http://access.bl.uk/ark:/81055/vdc_100137789701.0x000023